Trial Profile
Impact of a treatment with zoledronic acid on bone mineral density in patients with metastatic castration-resistant prostate cancer, chemo-naïve and receiving abiraterone acetate
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Zoledronic acid (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacodynamics
- Acronyms AZALEE
- 26 Jun 2015 New trial record